# Impact of ADM in Reduction of Surgical Complexity of Breast Reconstructions With Implants (Nava)

> **NCT01853436** · NA · TERMINATED · sponsor: **LifeCell** · enrollment: 36 (actual)

## Conditions studied

- Patients With Breast Cancer Requiring Mastectomy and Suitable for Reconstruction

## Interventions

- **DEVICE:** Strattice™ Reconstructive Tissue Matrix

## Key facts

- **NCT ID:** NCT01853436
- **Lead sponsor:** LifeCell
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-03
- **Primary completion:** 2017-04
- **Final completion:** 2017-07
- **Target enrollment:** 36 (ACTUAL)
- **Why stopped:** Lifecell became part of Allergan; company deciscion
- **Last updated:** 2017-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01853436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01853436, "Impact of ADM in Reduction of Surgical Complexity of Breast Reconstructions With Implants (Nava)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01853436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*